Literature DB >> 11899457

Preventable adverse patient outcomes: a closed claims analysis of respiratory incidents.

S L Larson1, L Jordan.   

Abstract

Closed claims analysis of adverse anesthesia outcomes was initiated through the AANA Foundation in 1995 to examine adverse outcomes of anesthesia care provided by Certified Registered Nurse Anesthetists (CRNAs). A research team of 8 CRNAs using an instrument incorporating more than 150 variables undertook document analyses of closed claim files. All files reviewed involved incidents in which the CRNA named in the policy was potentially involved in the adverse patient outcome. Thirty-eight percent (58/151) of CRNA-related claims involved a respiratory incident as the primary cause of the negative patient outcome. Patient outcomes involving respiratory incidents were more likely to result in death or permanent injury compared with nonrespiratory incidents (P < .01). Reviewers found that respiratory claims were more likely to have involved inappropriate anesthesia management (P < .01), more likely to have involved a lack of vigilance (P < .01), and more likely to have been judged by the reviewer as preventable (P < .01). A higher percentage of respiratory incidents occurred in emergency cases (75% vs 34%, P < .01) and in cases involving general anesthesia (44% vs 17%, P < .01). Adverse respiratory incidents are largely preventable and frequently result in serious patient morbidity and mortality.

Entities:  

Mesh:

Year:  2001        PMID: 11899457

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  2 in total

1.  Predictors of intubation in children.

Authors:  Sapna A Nikhar; Vinod K Grover; Preethy Joseph Mathew
Journal:  Indian J Pediatr       Date:  2010-09-03       Impact factor: 1.967

2.  Organization and representation of patient safety data: current status and issues around generalizability and scalability.

Authors:  Aziz A Boxwala; Meghan Dierks; Maura Keenan; Susan Jackson; Robert Hanscom; David W Bates; Luke Sato
Journal:  J Am Med Inform Assoc       Date:  2004-08-06       Impact factor: 4.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.